Drug · DIN 02302160
ERAXIS
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 19, 2013; first marketed January 25, 2008.
- Drug Identification Number (DIN)
- 02302160
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Anidulafungin J02AX06
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ANIDULAFUNGIN | 100 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 14, 2007: NOC 9171New Drug Submission (NDS)
Other DINs named ERAXIS
- DIN 02330695 · Marketed